Aerie Pharmaceuticals Inc.

NAS: AERI

GO
/marketstate/country/us

After Hours

/zigman2/quotes/200692066/composite

$

11.43

Change

0.00 0.00%

Volume

Volume 8,554

Sep 29, 2020, 4:04 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/200692066/composite

Today's close

$ 11.03

$ 11.43

Change

+0.40 +3.63%

Day low

Day high

$10.97

$11.46

Open
Open: 11.13

52 week low

52 week high

$10.22

$26.26

Open

Market cap

$513.05M

Average volume

716,942

P/E ratio

N/A

Rev. per Employee

$68,501

EPS

-4.42

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/aeri

MarketWatch News on AERI

  1. Aerie Pharmaceuticals stock price target cut to $34 from $54 at Mizuho

    7:12 a.m. April 13, 2020

    - Tomi Kilgore

  2. Aerie Pharmaceuticals started at buy with $32 stock price target at SunTrust RH

    9:55 a.m. Jan. 9, 2020

    - Tomi Kilgore

  3. Aerie Pharmaceuticals stock price target cut to $80 from $87 at Stifel Nicolaus

    7:42 a.m. July 10, 2019

    - Tomi Kilgore

  4. How to spot risky biotech companies and six to avoid now

    6:14 a.m. Jan. 17, 2019

    - Michael Brush

  5. Aerie Pharma eye drug Rhopressa approved by FDA

    5:47 p.m. Dec. 18, 2017

    - Jeremy C. Owens

  6. Aerie Pharmaceuticals stock halted ahead of announcement of FDA approval of Rhopressa

    5:07 p.m. Dec. 18, 2017

    - MarketWatch

  7. Aerie Pharmaceuticals stock halted as FDA committee reviews glaucoma treatment

    7:22 a.m. Oct. 13, 2017

    - Ciara Linnane

  8. Aerie Pharma stock surges 31% on positive late-stage trial results for glaucoma eye drops

    4:15 p.m. May 24, 2017

    - Emma Court

  9. Aerie Pharmaceuticals downgraded to market perform from strong buy at Raymond James

    8:58 a.m. March 9, 2017

    - Trey Williams

  10. Aerie Pharmaceuticals stock price target raised to $56 from $50 at Canaccord Genuity

    11:05 a.m. March 8, 2017

    - Tomi Kilgore

  11. VIX tags multi-year lows amid bullish S&P 500 technical breakout

    12:17 p.m. Jan. 27, 2017

    - Michael Ashbaugh

  12. Dow books 7th straight weekly gain in muted preholiday trade

    5:32 p.m. Dec. 23, 2016

    - Carla Mozee

  13. Aerie Stock Hits High, Holder Sells $2 Million

    11:52 a.m. Oct. 14, 2016

    - Barron's Online

  14. Aerie Pharma announces secondary offering after big stock jump

    5:17 p.m. Sept. 15, 2016

    - Wallace Witkowski

  15. U.S. stocks close higher as Apple helps spark broad tech rally

    4:45 p.m. Sept. 15, 2016

    - Anora Mahmudova

  16. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/aeri

Other News on AERI

  1. Aerie Pharma on go with mid-stage study of eye drop for dry eye

    7:40 a.m. Today

    - Seeking Alpha

  2. Raymond James Keeps a Hold Rating on Aerie Pharma (AERI)

    4:45 p.m. Sept. 28, 2020

    - SmarterAnalyst

  3. Aerie Pharma (AERI) Gets a Buy Rating from Needham

    8:35 a.m. Sept. 25, 2020

    - SmarterAnalyst

  4. Aerie Pharma (AERI) Gets a Hold Rating from Raymond James

    4:35 p.m. Sept. 24, 2020

    - SmarterAnalyst

  5. Aerie Pharma (AERI) Receives a Buy from Oppenheimer

    3:15 p.m. Sept. 24, 2020

    - SmarterAnalyst

  6. Aerie Pharma (AERI) Receives a Buy from Mizuho Securities

    11:45 a.m. Sept. 24, 2020

    - SmarterAnalyst

  7. Aerie' Roclanda on par with Allergan's Ganfort in glaucoma study

    7:32 a.m. Sept. 24, 2020

    - Seeking Alpha

  8. Raymond James Keeps a Hold Rating on Aerie Pharma (AERI)

    4:45 p.m. Sept. 21, 2020

    - SmarterAnalyst

  9. Needham Thinks Aerie Pharma’s Stock is Going to Recover

    9:45 a.m. Sept. 18, 2020

    - SmarterAnalyst

  10. FDA OKs Aerie Pharma's production facility in Ireland

    7:00 a.m. Sept. 15, 2020

    - Seeking Alpha

  11. FDA OKs Aerie Pharma's Rhopressa production facility in Ireland

    7:00 a.m. Sept. 15, 2020

    - Seeking Alpha

  12. Mizuho Securities Remains a Buy on Aerie Pharma (AERI)

    5:35 a.m. Sept. 15, 2020

    - SmarterAnalyst

  13. Aerie Pharma (AERI) Receives a Hold from Raymond James

    4:46 p.m. Sept. 14, 2020

    - SmarterAnalyst

  14. Needham Thinks Aerie Pharma’s Stock is Going to Recover

    9:25 a.m. Sept. 11, 2020

    - SmarterAnalyst

  15. Aerie initiated Buy at Guggenheim

    3:29 p.m. Sept. 8, 2020

    - Seeking Alpha

  16. Raymond James Remains a Hold on Aerie Pharma (AERI)

    7:25 a.m. Sept. 8, 2020

    - SmarterAnalyst

  17. Graybug Vision readies IPO

    3:33 p.m. Sept. 5, 2020

    - Seeking Alpha

  18. Why Is Aerie (AERI) Down 3.6% Since Last Earnings Report?

    11:31 a.m. Sept. 5, 2020

    - Zacks.com

  19. Loading more headlines...
/news/pressrelease/company/us/aeri

Press Releases on AERI

  1. Loading more headlines...

Rates »

Link to MarketWatch's Slice.